Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.

European journal of pediatrics - 1 Aug 1994

Larsen J, Campbell S, Faragher E B, Götz M, Eichler I, Waldherr S, Dobianer K, Spona J

Abstract excerpt

This study investigated the clinical usefulness of screening for cystic fibrosis (CF) in 19,992 newborns, over 39 months, in an Austrian population. Immunoreactive serum trypsin (IRT) determination was followed by sweat chloride analysis (sweat test) to establish diagnosis. In a retrospective analysis covering 6 months of the study period, individuals who were considered to be at risk after IRT estimation (n =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genotype

Share to Infant, Newborn

Share to Neonatal Screening

Share to Sensitivity and Specificity

Share to Trypsin

Source

Identifiers

PMID: 7957403
DOI: 10.1007/BF02190660

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.PMID 7957403Read ↗

Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses.Semantic proximity Read ↗

Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.Semantic proximity Read ↗

Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.Semantic proximity Read ↗

Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.Semantic proximity Read ↗

Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.Semantic proximity Read ↗

Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.Semantic proximity Read ↗

Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.Semantic proximity Read ↗

Newborn screening for cystic fibrosis in Serbia: a pilot study.Semantic proximity Read ↗

Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden.Semantic proximity Read ↗

Blood immunoreactive trypsinogen concentrations are genetically determined in healthy and cystic fibrosis newborns.Semantic proximity Read ↗

Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy.Semantic proximity Read ↗

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.